Atlas Trials

The Role of Budesonide Intrapolyp Injection in the Management of Type 2 Chronic Rhinosinusitis

Clinical trial NCT05931744 · COMPLETED

Trial details

NCT number
NCT05931744
Sponsor
Kafrelsheikh University
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Chronic Rhinosinusitis With Nasal Polyps
Start date
2021-05-01
Primary completion
2023-02-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.